Dynamics of the Microbiota and Its Relationship with Post-COVID-19 Syndrome
Coronavirus disease (COVID-19) is an infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which can be asymptomatic or present with multiple organ dysfunction. Many infected individuals have chronic alterations associated with neuropsychiatric, endocrine, gastrointestina...
Gespeichert in:
Veröffentlicht in: | International journal of molecular sciences 2023-10, Vol.24 (19), p.14822 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 19 |
container_start_page | 14822 |
container_title | International journal of molecular sciences |
container_volume | 24 |
creator | Moreno-Corona, Nidia Carolina López-Ortega, Orestes Pérez-Martínez, Cesar Augusto Martínez-Castillo, Macario De Jesús-González, Luis Adrián León-Reyes, Guadalupe León-Juárez, Moisés |
description | Coronavirus disease (COVID-19) is an infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which can be asymptomatic or present with multiple organ dysfunction. Many infected individuals have chronic alterations associated with neuropsychiatric, endocrine, gastrointestinal, and musculoskeletal symptoms, even several months after disease onset, developing long-COVID or post-acute COVID-19 syndrome (PACS). Microbiota dysbiosis contributes to the onset and progression of many viral diseases, including COVID-19 and post-COVID-19 manifestations, which could serve as potential diagnostic and prognostic biomarkers. This review aimed to discuss the most recent findings on gut microbiota dysbiosis and its relationship with the sequelae of PACS. Elucidating these mechanisms could help develop personalized and non-invasive clinical strategies to identify individuals at a higher risk of experiencing severe disease progression or complications associated with PACS. Moreover, the review highlights the importance of targeting the gut microbiota composition to avoid dysbiosis and to develop possible prophylactic and therapeutic measures against COVID-19 and PACS in future studies. |
doi_str_mv | 10.3390/ijms241914822 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10573029</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A771910243</galeid><sourcerecordid>A771910243</sourcerecordid><originalsourceid>FETCH-LOGICAL-c460t-55c33c27dc032049d45f0a3e6622d3e908127c5219fe25ee78a5fcc8c16842f53</originalsourceid><addsrcrecordid>eNptkctvVCEUh4nR2Icu3ZO4cXMrHF6XlWmmWifW1PjaEsqFDpN7YXphNPPfy6SNOsawOITzOx85-RB6QckZY5q8juupAKea8h7gETqmHKAjRKrHf92P0Ekpa0KAgdBP0RFTPeOgyDH6cLFLdoqu4BxwXXn8Mbo538RcLbZpwMta8Gc_2hpzKqu4wT9jXeFPudRucf19edFRjb_s0jDnyT9DT4Idi3_-UE_Rt3dvvy7ed1fXl8vF-VXnuCS1E8Ix5kANjjAgXA9cBGKZlxJgYF6TnoJyAqgOHoT3qrciONc7KnsOQbBT9Oaeu9neTH5wPtXZjmYzx8nOO5NtNIedFFfmNv8wlAjFCOhGePVAmPPd1pdqplicH0ebfN4WA71STAMAa9GX_0TXeTuntt8-JaUkshd_Urd29CamkNvHbg8150o1OwT4nnX2n1Q7g28KcvIhtveDge5-oDkpZfbh95KUmL1-c6Cf_QLOYZ4v</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2876660685</pqid></control><display><type>article</type><title>Dynamics of the Microbiota and Its Relationship with Post-COVID-19 Syndrome</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Moreno-Corona, Nidia Carolina ; López-Ortega, Orestes ; Pérez-Martínez, Cesar Augusto ; Martínez-Castillo, Macario ; De Jesús-González, Luis Adrián ; León-Reyes, Guadalupe ; León-Juárez, Moisés</creator><creatorcontrib>Moreno-Corona, Nidia Carolina ; López-Ortega, Orestes ; Pérez-Martínez, Cesar Augusto ; Martínez-Castillo, Macario ; De Jesús-González, Luis Adrián ; León-Reyes, Guadalupe ; León-Juárez, Moisés</creatorcontrib><description>Coronavirus disease (COVID-19) is an infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which can be asymptomatic or present with multiple organ dysfunction. Many infected individuals have chronic alterations associated with neuropsychiatric, endocrine, gastrointestinal, and musculoskeletal symptoms, even several months after disease onset, developing long-COVID or post-acute COVID-19 syndrome (PACS). Microbiota dysbiosis contributes to the onset and progression of many viral diseases, including COVID-19 and post-COVID-19 manifestations, which could serve as potential diagnostic and prognostic biomarkers. This review aimed to discuss the most recent findings on gut microbiota dysbiosis and its relationship with the sequelae of PACS. Elucidating these mechanisms could help develop personalized and non-invasive clinical strategies to identify individuals at a higher risk of experiencing severe disease progression or complications associated with PACS. Moreover, the review highlights the importance of targeting the gut microbiota composition to avoid dysbiosis and to develop possible prophylactic and therapeutic measures against COVID-19 and PACS in future studies.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms241914822</identifier><identifier>PMID: 37834270</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>B cells ; Bacteria ; Coronaviruses ; COVID-19 ; Development and progression ; Dyspnea ; Health aspects ; HIV ; Homeostasis ; Human immunodeficiency virus ; Immune system ; Infections ; Inflammation ; Influenza ; Long COVID ; Lung diseases ; Lungs ; Metabolites ; Microbiota ; Microbiota (Symbiotic organisms) ; Pathogens ; Remission (Medicine) ; Review ; Severe acute respiratory syndrome ; Severe acute respiratory syndrome coronavirus 2 ; Viral infections ; Virus diseases ; Viruses</subject><ispartof>International journal of molecular sciences, 2023-10, Vol.24 (19), p.14822</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c460t-55c33c27dc032049d45f0a3e6622d3e908127c5219fe25ee78a5fcc8c16842f53</citedby><cites>FETCH-LOGICAL-c460t-55c33c27dc032049d45f0a3e6622d3e908127c5219fe25ee78a5fcc8c16842f53</cites><orcidid>0000-0003-1415-6260 ; 0000-0002-5726-5953 ; 0000-0002-0319-1661 ; 0000-0001-5248-0454</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573029/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573029/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Moreno-Corona, Nidia Carolina</creatorcontrib><creatorcontrib>López-Ortega, Orestes</creatorcontrib><creatorcontrib>Pérez-Martínez, Cesar Augusto</creatorcontrib><creatorcontrib>Martínez-Castillo, Macario</creatorcontrib><creatorcontrib>De Jesús-González, Luis Adrián</creatorcontrib><creatorcontrib>León-Reyes, Guadalupe</creatorcontrib><creatorcontrib>León-Juárez, Moisés</creatorcontrib><title>Dynamics of the Microbiota and Its Relationship with Post-COVID-19 Syndrome</title><title>International journal of molecular sciences</title><description>Coronavirus disease (COVID-19) is an infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which can be asymptomatic or present with multiple organ dysfunction. Many infected individuals have chronic alterations associated with neuropsychiatric, endocrine, gastrointestinal, and musculoskeletal symptoms, even several months after disease onset, developing long-COVID or post-acute COVID-19 syndrome (PACS). Microbiota dysbiosis contributes to the onset and progression of many viral diseases, including COVID-19 and post-COVID-19 manifestations, which could serve as potential diagnostic and prognostic biomarkers. This review aimed to discuss the most recent findings on gut microbiota dysbiosis and its relationship with the sequelae of PACS. Elucidating these mechanisms could help develop personalized and non-invasive clinical strategies to identify individuals at a higher risk of experiencing severe disease progression or complications associated with PACS. Moreover, the review highlights the importance of targeting the gut microbiota composition to avoid dysbiosis and to develop possible prophylactic and therapeutic measures against COVID-19 and PACS in future studies.</description><subject>B cells</subject><subject>Bacteria</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Development and progression</subject><subject>Dyspnea</subject><subject>Health aspects</subject><subject>HIV</subject><subject>Homeostasis</subject><subject>Human immunodeficiency virus</subject><subject>Immune system</subject><subject>Infections</subject><subject>Inflammation</subject><subject>Influenza</subject><subject>Long COVID</subject><subject>Lung diseases</subject><subject>Lungs</subject><subject>Metabolites</subject><subject>Microbiota</subject><subject>Microbiota (Symbiotic organisms)</subject><subject>Pathogens</subject><subject>Remission (Medicine)</subject><subject>Review</subject><subject>Severe acute respiratory syndrome</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Viral infections</subject><subject>Virus diseases</subject><subject>Viruses</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptkctvVCEUh4nR2Icu3ZO4cXMrHF6XlWmmWifW1PjaEsqFDpN7YXphNPPfy6SNOsawOITzOx85-RB6QckZY5q8juupAKea8h7gETqmHKAjRKrHf92P0Ekpa0KAgdBP0RFTPeOgyDH6cLFLdoqu4BxwXXn8Mbo538RcLbZpwMta8Gc_2hpzKqu4wT9jXeFPudRucf19edFRjb_s0jDnyT9DT4Idi3_-UE_Rt3dvvy7ed1fXl8vF-VXnuCS1E8Ix5kANjjAgXA9cBGKZlxJgYF6TnoJyAqgOHoT3qrciONc7KnsOQbBT9Oaeu9neTH5wPtXZjmYzx8nOO5NtNIedFFfmNv8wlAjFCOhGePVAmPPd1pdqplicH0ebfN4WA71STAMAa9GX_0TXeTuntt8-JaUkshd_Urd29CamkNvHbg8150o1OwT4nnX2n1Q7g28KcvIhtveDge5-oDkpZfbh95KUmL1-c6Cf_QLOYZ4v</recordid><startdate>20231001</startdate><enddate>20231001</enddate><creator>Moreno-Corona, Nidia Carolina</creator><creator>López-Ortega, Orestes</creator><creator>Pérez-Martínez, Cesar Augusto</creator><creator>Martínez-Castillo, Macario</creator><creator>De Jesús-González, Luis Adrián</creator><creator>León-Reyes, Guadalupe</creator><creator>León-Juárez, Moisés</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1415-6260</orcidid><orcidid>https://orcid.org/0000-0002-5726-5953</orcidid><orcidid>https://orcid.org/0000-0002-0319-1661</orcidid><orcidid>https://orcid.org/0000-0001-5248-0454</orcidid></search><sort><creationdate>20231001</creationdate><title>Dynamics of the Microbiota and Its Relationship with Post-COVID-19 Syndrome</title><author>Moreno-Corona, Nidia Carolina ; López-Ortega, Orestes ; Pérez-Martínez, Cesar Augusto ; Martínez-Castillo, Macario ; De Jesús-González, Luis Adrián ; León-Reyes, Guadalupe ; León-Juárez, Moisés</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c460t-55c33c27dc032049d45f0a3e6622d3e908127c5219fe25ee78a5fcc8c16842f53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>B cells</topic><topic>Bacteria</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Development and progression</topic><topic>Dyspnea</topic><topic>Health aspects</topic><topic>HIV</topic><topic>Homeostasis</topic><topic>Human immunodeficiency virus</topic><topic>Immune system</topic><topic>Infections</topic><topic>Inflammation</topic><topic>Influenza</topic><topic>Long COVID</topic><topic>Lung diseases</topic><topic>Lungs</topic><topic>Metabolites</topic><topic>Microbiota</topic><topic>Microbiota (Symbiotic organisms)</topic><topic>Pathogens</topic><topic>Remission (Medicine)</topic><topic>Review</topic><topic>Severe acute respiratory syndrome</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Viral infections</topic><topic>Virus diseases</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moreno-Corona, Nidia Carolina</creatorcontrib><creatorcontrib>López-Ortega, Orestes</creatorcontrib><creatorcontrib>Pérez-Martínez, Cesar Augusto</creatorcontrib><creatorcontrib>Martínez-Castillo, Macario</creatorcontrib><creatorcontrib>De Jesús-González, Luis Adrián</creatorcontrib><creatorcontrib>León-Reyes, Guadalupe</creatorcontrib><creatorcontrib>León-Juárez, Moisés</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moreno-Corona, Nidia Carolina</au><au>López-Ortega, Orestes</au><au>Pérez-Martínez, Cesar Augusto</au><au>Martínez-Castillo, Macario</au><au>De Jesús-González, Luis Adrián</au><au>León-Reyes, Guadalupe</au><au>León-Juárez, Moisés</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dynamics of the Microbiota and Its Relationship with Post-COVID-19 Syndrome</atitle><jtitle>International journal of molecular sciences</jtitle><date>2023-10-01</date><risdate>2023</risdate><volume>24</volume><issue>19</issue><spage>14822</spage><pages>14822-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Coronavirus disease (COVID-19) is an infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which can be asymptomatic or present with multiple organ dysfunction. Many infected individuals have chronic alterations associated with neuropsychiatric, endocrine, gastrointestinal, and musculoskeletal symptoms, even several months after disease onset, developing long-COVID or post-acute COVID-19 syndrome (PACS). Microbiota dysbiosis contributes to the onset and progression of many viral diseases, including COVID-19 and post-COVID-19 manifestations, which could serve as potential diagnostic and prognostic biomarkers. This review aimed to discuss the most recent findings on gut microbiota dysbiosis and its relationship with the sequelae of PACS. Elucidating these mechanisms could help develop personalized and non-invasive clinical strategies to identify individuals at a higher risk of experiencing severe disease progression or complications associated with PACS. Moreover, the review highlights the importance of targeting the gut microbiota composition to avoid dysbiosis and to develop possible prophylactic and therapeutic measures against COVID-19 and PACS in future studies.</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>37834270</pmid><doi>10.3390/ijms241914822</doi><orcidid>https://orcid.org/0000-0003-1415-6260</orcidid><orcidid>https://orcid.org/0000-0002-5726-5953</orcidid><orcidid>https://orcid.org/0000-0002-0319-1661</orcidid><orcidid>https://orcid.org/0000-0001-5248-0454</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1422-0067 |
ispartof | International journal of molecular sciences, 2023-10, Vol.24 (19), p.14822 |
issn | 1422-0067 1661-6596 1422-0067 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10573029 |
source | MDPI - Multidisciplinary Digital Publishing Institute; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | B cells Bacteria Coronaviruses COVID-19 Development and progression Dyspnea Health aspects HIV Homeostasis Human immunodeficiency virus Immune system Infections Inflammation Influenza Long COVID Lung diseases Lungs Metabolites Microbiota Microbiota (Symbiotic organisms) Pathogens Remission (Medicine) Review Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Viral infections Virus diseases Viruses |
title | Dynamics of the Microbiota and Its Relationship with Post-COVID-19 Syndrome |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T05%3A00%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dynamics%20of%20the%20Microbiota%20and%20Its%20Relationship%20with%20Post-COVID-19%20Syndrome&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Moreno-Corona,%20Nidia%20Carolina&rft.date=2023-10-01&rft.volume=24&rft.issue=19&rft.spage=14822&rft.pages=14822-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms241914822&rft_dat=%3Cgale_pubme%3EA771910243%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2876660685&rft_id=info:pmid/37834270&rft_galeid=A771910243&rfr_iscdi=true |